Treatment of Ph1-positive chronic myelogenous leukemia in children: Comparison between allogeneic bone marrow transplantation and conventional chemotherapy

Haematologica

Volumn 83, Issue 11, 1998, Pages 981-984

  Muñoz, Arturo ^a   Bureo, Encarna ^b   Ortega, Juan José ^c   Richard, Carlos ^b   Olivé, Teresa ^c   Maldonado, Maria Soledad ^a   Madero, Luis ^d   Díaz, Miguel Angel ^d  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

Bone marrow transplantation; Chemotherapy; Children; Chronic myeloid leukemia

Indexed keywords

ALPHA INTERFERON; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HYDROXYUREA; METHOTREXATE; PREDNISONE;

ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD MORTALITY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; MALE; PHILADELPHIA 1 CHROMOSOME; POSTOPERATIVE COMPLICATION; RELAPSE; WHOLE BODY RADIATION;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; BUSULFAN; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYUREA; INTERFERON-ALPHA; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; LIFE TABLES; MALE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SPAIN; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 0032446345     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Altman AJ. Chronic leukemias of childhood. Pediatr Clin North Am 1988; 35:765-87.
2. Marin T, Butturini A, Kantarjian H. Survival of children with myeloid leukemia. Am J Pediatr Hematol Oncol 1992; 14:229-32.
3. Kantarjian H, O'Brien S, Ardelini P, et al. Treatment of chronic myelogenous leukemia: current status and investigational options. Blood 1996; 87:3069-81.
4. Van Ree F, Szydo RM, Hermans J, et al. Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1997; 20:553-60.
5. Champlin RE, Goldman JM, Gale RP. Bone marrow transplantation in chronic myelogenous leukemia. Semin Hematol 1988; 25:74-80.
6. Thoms ED, Clift RA. Indications for marrow transplantation in chronic myelogenous leukemia. Blood 1989; 73:861-4.
7. Klingebiel T, Crentzig U, Ehninger G, et al. Bone marrow transplantation in comparison with conventional therapy in children with adult type chronic myelogenous leukemia. Bone Marrow Transplant 1990; 5:317-20.
8. Gamis AS, Haake R, McGlave PH, et al. Unrelated donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children. J Clin Oncol 1993; 11:834-8.
9. Peris R, ed. Registro Nacional de Tumores Infantiles. Estadísticas Básicas. Valencia: Publicaciones de la Consejería de Salud de la Generalitat Valenciana, 1994.
10. Carella AM, Frassoni F, Melo J, et al. New insights in biology and current therapeutic options for patients with chronic myelogenous leukemia. Haematologica 1997; 82:478-95.
11. Thomas ED, Clift RA, Fefer A, et al. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med 1986; 104:155-63.
12. Marti PJ, Clift RA, Fisher LD, et al. Marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration. Blood 1988; 72:1978-84.
13. Beelen DW, Graeven U, Elmaaglaci AH, et al. Prolonged administration of interferon-alpha in patients with chronic-phase Philadelphia chromosome positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome. Blood 1995; 85:2981-90.
14. Bar BM, Schattenberg A, Mensink EJ, et al. Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation. J Clin Oncol 1993; 11:513-9.
15. Schwinger W, Urban C, Mache DJ, et al. Adoptive immunotransfer with viable donor mononuclear cells for recurrent myelogenous leukemia after allogeneic bone marrow transplantation in two children. Pediatr Hematol Oncol 1995; 12:47-54.
16. Giralt SA, Champlin RE. Leukemia relapse after allogeneic bone marrow transplantation: a review. Blood 1994; 84:3603-12.
17. Cullis JO, Schwarer AP, Hughes TP, et al. Second transplants for patients with chronic myeloid leukemia in relapse after original transplant with T-depleted donor marrow: feasibility of using busulphan alone for reconditioning. Br J Haematol 1992; 80:33-9.
18. Muñoz A, Rosique P, Otheo E, et al. Second HLA-identical sibling transplants for recurrence of chronic myeloid leukemia adult type in children [abstract]. Bone Marrow Transplant 1997; 19 (Suppl. 1):P-477.
19. Santucci MA, Saglio G, Tura S. Pathogenesis and progression of chronic myeloid leukemia. Haematologica 1996; 81:63-76.
20. Anonymous. Treatment of the individual patient with chronic myelogenous leukemia. Haematologica 1997; 82:385-6.